Comparing QuantiFERON-tuberculosis gold, T-SPOT tuberculosis and tuberculin skin test in HIV-infected individuals from a low prevalence tuberculosis country

AIDS

Volumn 22, Issue 18, 2008, Pages 2471-2479

  Stephan, Christoph ^a,d   Wolf, Timo ^b   Goetsch, Udo ^d   Bellinger, Oswald ^d   Nisius, Gabriele ^a   Oremek, Gerhard ^c   Rakus, Zbigniew ^b   Gottschalk, René ^d   Stark, Sonja ^d   Brodt, Hans Reinhard ^b   Staszewski, Schlomo ^a  

^a HIV Center

^b Medical Department II

^c Pneumology Allergology and Cystic Fibrosis   (Germany)

^d UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

AIDS; Human immunodeficiency virus infection; Latent tuberculosis infection; Opportunistic infection; QuantiFERON tuberculosis Gold; T SPOT tuberculosis; tuberculin skin test

Indexed keywords

GAMMA INTERFERON; VIRUS RNA;

ADULT; AGED; ARTICLE; CD4 LYMPHOCYTE COUNT; CLINICAL FEATURE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE FUNCTION TEST; IMMUNOCOMPETENCE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OUTPATIENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUANTIFERON TUBERCULOSIS GOLD; RISK FACTOR; T SPOT TUBERCULOSIS; TUBERCULIN TEST; TUBERCULOSIS; UNIVERSITY HOSPITAL;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; CD4 LYMPHOCYTE COUNT; EPIDEMIOLOGIC METHODS; FALSE POSITIVE REACTIONS; FEMALE; HIV-1; HUMANS; MALE; RISK FACTORS; TUBERCULIN TEST; TUBERCULOSIS;

EID: 57349168026     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAD.0b013e3283188415     Document Type: Article

References (26)

1. Elzi L, Schlegel M, Weber R, Hirschel B, Cavassini M, Schmid P, et al., for Swiss HIV Cohort Study. Reducing tuberculosis incidence by tuberculin skin testing, preventive treatment, and antiretroviral therapy in an area of low tuberculosis transmission. Clin Infect Dis 2007;44:94-102.
2. Lawn SD, Badri M, Wood R. Tuberculosis among HIV-infected patients receiving HAART: long term incidence and risk factors in a South African cohort. AIDS 2005;19:2109-2116.
3. Judson FN, Feldman RA. Mycobacterial skin tests in humans 12 years after infection with Mycobacterium marinum. Am Rev Respir Dis 1974;109:544-547.
4. Snider DE Jr. Bacille Calmette-Guérin vaccinations and tuberculin skin tests. JAMA 1985;253:3438-3439.
5. Selwyn PA, Sckell BM, Alcabes P, Friedland GH, Klein RS, Schoenbaum EE. High risk of active tuberculosis in HIV-infected drug users with cutaneous anergy. JAMA 1992;268: 504-509.
6. Luetkemeyer AF, Charlebois ED, Flores LL, Bangsberg DR, Deeks SG, Martin JN, et al. Comparison of an interferon-gamma release assay with tuberculin skin testing in HIV-infected individuals. Am J Respir Crit Care Med 2007;175:737-742.
7. Ferrara G, Losi M, D'Amico R, Roversi P, Piro R, Meacci M, et al. Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study. Lancet 2006;367:1328-1334.
8. American Thoracic Society. Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med 2000;161:S221-S247.
9. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33:159-174.
10. Altman DG. Practical statistics for medical research. London, UK: Chapman & Hall; 1991.
11. Singh D, Sutton C, Woodcock A. Tuberculin test measurement - variability due to the time of reading. Chest 2002;122:1299- 1301.
12. Pathan AA, Wilkinson KA, Klenerman P, McShane H, Davidson RN, Pasvol G, et al. Direct ex vivo analysis of antigen-specific IFN-gamma-secreting CD4 T cells in Mycobacterium tuberculosisinfected individuals: associations with clinical disease state and effect of treatment. J Immunol 2001;167:5217-5225.
13. Liebeschuetz S, Bamber S, Ewer K, Deeks J, Pathan AA, Lalvani A. Diagnosis of tuberculosis in South African children with a T-cell-based assay: a prospective cohort study. Lancet 2004;364:2196-2203.
14. Chapman AL, Munkanta M, Wilkinson KA, Pathan AA, Ewer K, Ayles H, et al. Rapid detection of active and latent tuberculosis infection in HIV-positive individuals by enumeration of Mycobacterium tuberculosis-specific T cells. AIDS 2002;16: 2285-2293.
15. Lalvani A, Pathan AA, McShane H, Wilkinson RJ, Latif M, Conlon CP, et al. Rapid detection of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Am J Respir Crit Care Med 2001;163:824-828.
16. Mori T, Sakatani M, Yamagishi F, Takashima T, Kawabe Y, Nagao K, et al. Specific detection of tuberculosis infection: an interferon-gamma- based assay using new antigens. Am J Respir Crit Care Med 2004;170:59-64.
17. Kang YA, Lee HW, Yoon HI, Cho B, Han SK, Shim YS, et al. Discrepancy between the tuberculin skin test and the wholeblood interferon gamma assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country. JAMA 2005;293:2756- 2761.
18. Menzies D, Pai M, Comstock G. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection - areas of uncertainty and recommendations for research. Ann Intern Med 2007;146:340-354.
19. Pai M, Zwerling A, Menzies D. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection - an update. Ann Intern Med 2008;149:177-184.
20. Brock I, Weldingh K, Lillebaek T, Follmann F, Andersen P. Comparison of tuberculin skin test and new specific blood test in tuberculosis contacts. Am J Respir Crit Care Med 2004;170:65-69.
21. Pai M, Cokhale K, Joshi R, Dogra S, Kalantri S, Mendiratta DK, et al. Mycobacterium tuberculosis infection in healthcare workers in rural India: comparison of a whole-blood interferon gamma assay with tuberculin skin testing. JAMA 2005;293:2746-2755.
22. Dosanjh DP, Hinks TS, Innes JA, Deeks JJ, Pasvol C, Hackforth S, et al. Improved diagnostic evaluation of suspected tuberculosis. Ann Intern Med 2008;148:325-336.
23. Mazurek GH, Weis SE, Moonan PK, Daley CL, Bernardo J, Lardizabal AA, et al. Prospective comparison of the tuberculin skin test and 2 whole-blood interferon-gamma release assays in persons with suspected tuberculosis. Clin Infect Dis 2007;45:837-845.
24. Lee JY, Choi HJ, Park IN, Hong SB, Oh YM, Lim CM, et al. Comparison of two commercial interferon-gamma assays for diagnosing Mycobacterium tuberculosis infection. Eur Respir J 2006;28:24-30.
25. Mazurek GH, Jereb J, Lobue P, lademarco MF, Metchock B, Vernon A. Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States. MMWR Recomm Rep 2005;54 (RR-15): 49-55.
26. Lawn SD, Bangani N, Vogt M, Bekker LG, Badri M, Ntobongwana M, et al. Utility of interferon-gamma ELISPOT assay responses in highly tuberculosis-exposed patients with advanced HIV infection in South Africa. BMC Infect Dis 2007; 7:99.